# Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™

> **NCT00678301** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 365 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** GSK Biologicals' Synflorix™
- **BIOLOGICAL:** GSK Biologicals' Polio Sabin™
- **BIOLOGICAL:** GSK Biologicals' Zilbrix™ Hib

## Key facts

- **NCT ID:** NCT00678301
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-18
- **Primary completion:** 2009-11-09
- **Final completion:** 2009-12-10
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2019-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678301, "Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00678301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*